Skip to main navigation Skip to search Skip to main content

Benzoquinone Ansamycin 17AAG Binds to Mitochondrial Voltage-Dependent Anion Channel and Inhibits Cell Invasion

  • Qian Xie
  • , Robert Wondergem
  • , Yuehai Shen
  • , Greg Cavey
  • , Jiyuan Ke
  • , Ryan Thompson
  • , Robert Bradley
  • , Jennifer Daugherty-Holtrop
  • , Yong Xu
  • , Edwin Chen
  • , Hanan Omar
  • , Neal Rosen
  • , David Wenkert
  • , H. Eric Xu
  • , George F. Vande Woud
  • Van Andel Research Institute
  • East Tennessee State University
  • Michigan State University
  • Memorial Sloan-Kettering Cancer Center

Research output: Contribution to journal › Article › peer-review

Abstract

Geldanamycin and its derivative 17AAG [17-(Allylamino)-17- demethoxygeldanamycin, telatinib] bind selectively to the Hsp90 chaperone protein and inhibit its function. We discovered that these drugs associate with mitochondria, specifically to the mitochondrial membrane voltage-dependent anion channel (VDAC) via a hydrophobic interaction that is independent of HSP90. In vitro, 17AAG functions as a Ca2+ mitochondrial regulator similar to benzoquinone-ubiquinones like Ub0. All of these compounds increase intracellular Ca2+ and diminish the plasma membrane cationic current, inhibiting urokinase activity and cell invasion. In contrast, the HSP90 inhibitor radicicol, lacking a bezoquinone moiety, has no measurable effect on cationic current and is less effective in influencing intercellular Ca2+ concentration. We conclude that some of the effects of 17-AAG and other ansamycins are due to their effects on VDAC and that this may play a role in their clinical activity.

Original languageAmerican English
JournalProceedings of the National Academy of Sciences of the United States of America
Volume108
DOIs
StatePublished - Mar 8 2011
Externally publishedYes

Keywords

  • benzoquinone ansamycin
  • calcium regulation

Cite this